专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2018223365A1 UV CURABLE SILICONE TERMINAL SEALANT 审中-公开
公开(公告)号：WO2018223365A1
公开(公告)日：2018-12-13
申请号：PCT/CN2017/087690
申请日：2017-06-09
申请人： DOW SILICONES CORPORATION , CHEN, Qi , FANG, Lei , WEI, Peng , ZHAO, Yi
发明人： CHEN, Qi , FANG, Lei , WEI, Peng , ZHAO, Yi
IPC分类号： C08L83/04 , C08L83/08
摘要： A UV curable silicone composition, comprising: A) an alkenyl-containing organopolysiloxane that has at least two alkenyl groups in each molecule, at least one alkenyl group on each terminus; B) a photoinitiator; C) a mercapto-functional organopolysiloxane that comprises 2 or more mercapto groups per molecule; D) a pigment; and one or both of E) and F), where E) is a silica and F) is a solvent comprising a organopolysiloxane having ≤ 12 silicon atoms.

2. 发明申请

WO2019014915A1 CURABLE ORGANOPOLYSILOXANE COMPOSITION AND CURED PRODUCT THEREOF 审中-公开
公开(公告)号：WO2019014915A1
公开(公告)日：2019-01-24
申请号：PCT/CN2017/093821
申请日：2017-07-21
申请人： DOW SILICONES CORPORATION , FANG, Lei , CHEN, Qi , HUANG, Qiang , ZHAO, Yi
发明人： FANG, Lei , CHEN, Qi , HUANG, Qiang , ZHAO, Yi
IPC分类号： C08L83/07 , C08L83/05 , C08L71/02 , C08K13/02 , C08K3/34 , C08L31/00 , C09J183/10 , C08G77/44 , H01L23/29 , H01L23/31 , H01L33/56
摘要： A curable organopolysiloxane composition comprising: (A) a diorganopolysiloxane having at least two silicon-bonded alkenyl groups per molecule; (B) an organopolysiloxane resin; (C) a mixture of (C 1 ) a diorganopolysiloxane endblocked with silicon-atom bonded hydrogen atom at both molecular terminals and (C 2 ) an organohydrogenpolysiloxane having at least three silicon-bonded hydrogen atoms per molecule; (D) a polyether having at least one aliphatic unsaturated group per molecule; and (E) a hydrosilylation catalyst.

3. 发明申请

WO2012068299A9 CBP/CATENIN ANTAGONISTS FOR ENHANCING ASYMMETRIC DIVISION OF SOMATIC STEM CELLS 审中-公开
公开(公告)号：WO2012068299A9
公开(公告)日：2012-05-24
申请号：PCT/US2011/061062
申请日：2011-11-16
申请人： UNIVERSITY OF SOUTHERN CALIFORNIA , KAHN, Michael , TEO, Jia-Ling , MCMILLAN, Michael , ZHAO, Yi , WU, Yongfeng
发明人： KAHN, Michael , TEO, Jia-Ling , MCMILLAN, Michael , ZHAO, Yi , WU, Yongfeng
IPC分类号： A61K31/519 , A61K31/5517 , A61K31/53 , A61P17/00

4. 发明申请

WO2012031293A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER 审中-公开
标题翻译：用于治疗癌症的组合物和方法
公开(公告)号：WO2012031293A1
公开(公告)日：2012-03-08
申请号：PCT/US2011/050518
申请日：2011-09-06
申请人： BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA , KABANOV, Alexander, V. , ALAKHOVA, Daria, Y. , ZHAO, Yi
发明人： KABANOV, Alexander, V. , ALAKHOVA, Daria, Y. , ZHAO, Yi
IPC分类号： A61K9/50 , A61K9/127
CPC分类号： A61K9/127 , A61K9/0019 , A61K31/704 , A61K47/10
摘要： The present invention provides compositions and methods for the treatment of cancer are provided.
摘要翻译：本发明提供了治疗癌症的组合物和方法。

5. 发明申请

WO2009151257A2 METHOD FOR CLEARING INVALID USER EQUIPMENT INFORMATION IN HOME NODE B-GATEWAY 审中-公开
标题翻译：在家庭网关B网关中清除无效用户设备信息的方法
公开(公告)号：WO2009151257A2
公开(公告)日：2009-12-17
申请号：PCT/KR2009/003084
申请日：2009-06-09
申请人： SAMSUNG ELECTRONICS CO., LTD. , ZHAO, Yi , HAN, Dajiang
发明人： ZHAO, Yi , HAN, Dajiang
IPC分类号： H04W8/02 , H04W36/00 , H04W88/16
CPC分类号： H04W36/0055 , H04W8/06 , H04W84/045 , H04W88/12
摘要： The present invention provides a method for clearing information in a HNB-GW, with a UE being located in a cell under the control of the home Node B, the method comprises steps of: monitoring by the home Node B whether the UE has moved away from the home Node B, the UE being in an idle state, CELL_DCH state, URA_PCH state, CELL_FACH state or CELL_PCH state; sending by the home Node B a message to the HNB-GW, if the UE has moved away; and clearing by the HNB-GW information on the UE in the HNB-GW. With the present invention, the HNB-GW can keep track of the resident state of UE and thus update UE information in real time.
摘要翻译：本发明提供一种用于清除HNB-GW中的信息的方法，其中UE位于家庭节点B的控制下的小区中，该方法包括以下步骤：由家庭节点B监视UE是否已经移走从家庭节点B，UE处于空闲状态，CELL_DCH状态，URA_PCH状态，CELL_FACH状态或CELL_PCH状态; 如果UE已经移开，由家庭节点B向HNB-GW发送消息; 并通过HNB-GW的HNB-GW信息清除关于UE的HNB-GW。通过本发明，HNB-GW可以跟踪UE的驻留状态，从而实时更新UE信息。

6. 发明申请

WO2005007093A2 USES OF IL-12 IN HEMATOPOIESIS 审中-公开
标题翻译： IL-12在HEMATOPOIESIS中的应用
公开(公告)号：WO2005007093A2
公开(公告)日：2005-01-27
申请号：PCT/US2004/021710
申请日：2004-07-06
申请人： ZHAO, Yi , CHEN, Tingchao , ANDERSON, French, W.
发明人： ZHAO, Yi , CHEN, Tingchao , ANDERSON, French, W.
IPC分类号： A61K
CPC分类号： A61K38/208
摘要： Embodiments of the present invention are directed to uses of Interleukin-12 (IL12) in enhancing or stimulating hematopoietis to yield hematopoietic recovery in a mammal in need. Particular embodiments of the invention are directed to uses of IL-12 as an adjuvant therapy to alleviate the hematopoietic toxicities associated with one or more treatment regimens used to combat a disease state. Other embodiments include uses of IL-12 to ameliorate various hematopoietic deficiencies. Still other embodiments are directed to uses of IL-12 for in-vivo proliferation of hematopoietic repopulating cells, hematopoietic progenitor cells and hematopoietic stem cells. Other disclosed embodiments are directed to uses of I1-12 for bone marrow preservation or recovery.
摘要翻译：本发明的实施方案涉及白细胞介素-12（IL12）在增强或刺激造血发生中以在需要的哺乳动物中产生造血恢复的用途。本发明的具体实施方案涉及IL-12用作辅助治疗以减轻与用于对抗疾病状态的一种或多种治疗方案相关的造血毒性的用途。其它实施方案包括IL-12的用途来改善各种造血缺陷。其它实施方案涉及IL-12用于造血再生细胞，造血祖细胞和造血干细胞的体内增殖的用途。其他公开的实施方案涉及I1-12用于骨髓保存或恢复。

7. 发明申请

WO2004060867A3 SECRETED PROTEIN FACTOR AND CELL MEMBRANE-BOUND SPLICE VARIANT 审中-公开
公开(公告)号：WO2004060867A3
公开(公告)日：2004-07-22
申请号：PCT/US2003/041742
申请日：2003-12-31
申请人： GALLAHER, Timothy, Kirk , BASILE, Lena, A. , WU, Kai-Jin , ZHAO, Yi , JARIWALA, Unnati
发明人： GALLAHER, Timothy, Kirk , BASILE, Lena, A. , WU, Kai-Jin , ZHAO, Yi , JARIWALA, Unnati
IPC分类号： C07K14/00 , A61K38/00 , A61K38/17 , C12N1/21 , C12N1/15 , C12N5/10 , C12N15/12 , C12N15/63
摘要： A novel mammalian protein system is disclosed. This system comprises a secreted protein factor and its related membrane-bound splice variant. These novel proteins have no homology to any known protein or class or protein, yet are ubiquitously expressed in nearly all tissue types. Also disclosed are novel nucleic acids that encode the novel polypeptides of the invention. The protein system was discovered in purified populations of murine hematopoieitc stem cells. The cDNAs of the invention were cloned from a murine hematopoietic lineage negative (Lin) library.

8. 发明公开

EP3688111A1 THERMALLY CONDUCTIVE COMPOSITION 审中-实审
公开(公告)号：EP3688111A1
公开(公告)日：2020-08-05
申请号：EP17927243.0
申请日：2017-09-29
申请人： Dow Silicones Corporation
发明人： LIU, Zhihua , WEI, Peng , YAN, Hexiang , ZHAO, Yi , CHEN, Qi , ZHU, Junmin
IPC分类号： C09J183/05 , C09J183/07

9. 发明公开

EP3655483A1 CURABLE ORGANOPOLYSILOXANE COMPOSITION AND CURED PRODUCT THEREOF 有权
公开(公告)号：EP3655483A1
公开(公告)日：2020-05-27
申请号：EP17918393.4
申请日：2017-07-21
申请人： Dow Silicones Corporation
发明人： FANG, Lei , CHEN, Qi , HUANG, Qiang , ZHAO, Yi
IPC分类号： C08L83/07 , C08L83/05 , C08L71/02 , C08K13/02 , C08K3/34 , C08L31/00 , C09J183/10 , C08G77/44 , H01L23/29 , H01L23/31 , H01L33/56

10. 发明申请

WO2005046726A2 METHODS FOR INHIBITING CELL GROWTH 审中-公开
标题翻译：抑制细胞生长的方法
公开(公告)号：WO2005046726A2
公开(公告)日：2005-05-26
申请号：PCT/US2004/037881
申请日：2004-11-12
申请人： ALLERGAN, INC. , ZHAO, Yi , CHANDRARATNA, Roshantha, A.
发明人： ZHAO, Yi , CHANDRARATNA, Roshantha, A.
IPC分类号： A61K45/06
CPC分类号： A61K45/06 , A61K31/00 , A61K2300/00
摘要： Cell growth is inhibited and/or cell death is induced in a cell by administering an RXR agonist and an inhibitor of casein kinase 1 α. A cell or a tissue can be screened for enhanced susceptibility to cell death or interference with cell growth. Conditions characterized by uncontrolled cell growth or proliferation, such as a cancer, can be treated with inhibitors of casein kinase 1 α.
摘要翻译：通过施用RXR激动剂和酪蛋白激酶1α的抑制剂，细胞生长被抑制和/或在细胞中诱导细胞死亡。可以筛选细胞或组织以增强细胞死亡或细胞生长干扰的易感性。可以用酪蛋白激酶1α抑制剂治疗以不受控制的细胞生长或增殖为特征的疾病，例如癌症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式